ArticlePediatric blood & cancer2016

Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.

Weili Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.